Persistence of Neutralizing Antibodies and Clinical Protection up to 12 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Elderly

BACKGROUND: Coronavirus disease 2019 (COVID-19) has severely affected the elderly, who are expected to display decreased immune responses due to immunosenescence. METHODS: This study retrospectively assesses neutralizing antibody (NAb) production up to 12 months after infection in long-term care pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Collarino, Rocco, Vauloup-Fellous, Christelle, Allemang-Trivalle, Aude, Mouna, Lina, Baudouin, Edouard-Pierre, Keravec, Héloise, Neiss, Marie, Bouchareb, Souhila, Bessai, Cherif, Sanchez-Tamayo, Jorge, Pujol, Tom, Trikha, Zeynab, Brunetti, Nicoletta, Sitbon-Guichardon, Magali, Roque-Afonso, Anne Marie, Trivalle, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709707/
https://www.ncbi.nlm.nih.gov/pubmed/36467299
http://dx.doi.org/10.1093/ofid/ofac613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709707/
https://www.ncbi.nlm.nih.gov/pubmed/36467299
http://dx.doi.org/10.1093/ofid/ofac613

Ejemplares similares